Nuvation Bio Inc Warrants
NUVB.WS
NUVB.WS was delisted on the 10th of February, 2026.
22 hedge funds and large institutions have $18.8M invested in Nuvation Bio Inc Warrants in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 2 closing their positions.
2% more capital invested
Capital invested by funds: $18.4M → $18.8M (+$369K)
4% less funds holding
Funds holding: 23 → 22 (-1)
21.06% less ownership
Funds ownership: 22.97% → 1.91% (-21%)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Clearline Capital
New York
|
+$77.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$217K |
| 2 |
CAC
Cowen and Company
New York
|
-$68K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.22K |
| 4 |
IP
Intellectus Partners
San Francisco,
California
|
-$780 |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$489 |
NUVB.WS Hedge Fund Activity: Q3 2021 in Review
22 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q3 2021, worth a combined $18.8M — up 2% from $18.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NUVB.WS and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest buyer was Clearline Capital, opening a new position worth an estimated $77.9K. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $217K sold.
- 22 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q3 2021, down from 23 in Q2 2021.
- Funds reported $18.8M of Nuvation Bio Inc Warrants stock for Q3 2021, up 2% quarter-over-quarter.
- 1 fund opened new Nuvation Bio Inc Warrants positions in Q3 2021 and 2 closed out, a net change of -1 holder.
- The largest Nuvation Bio Inc Warrants buyer in Q3 2021 was Clearline Capital, an estimated $77.9K added.
- The largest Nuvation Bio Inc Warrants seller in Q3 2021 was Cormorant Asset Management, an estimated $217K sold.
Based on aggregated 13F filings for Q3 2021.